Menu

CME Corner

Active Programs

Strategies for Achieving LDL-C Goals to Reduce ASCVD Risk

There are numerous treatment options available for the management of familial hypercholesterolemia (FH) and non-familial hypercholesterolemia, but many patients remain unable to achieve optimal reductions in their LDL-C levels. This interactive case-based activity will examine the consequences of elevated LDL-C and explore strategies for achieving target LDL-C goals. ...

  • Online Presentation Online Presentation
  • ACCME

Secondary Prevention of ASCVD: Novel Therapies to Improve Outcomes in Patients with Hypercholesterolemia (AANP Program ID 17012508)

This activity will examine the current discussions surrounding statin use and the potential application of PCSK9 inhibitors. *Learners will be redirected to the AANP website. ...

  • Online Presentation
  • AANP

Expired Programs

Improving Outcomes in Patients with Heart Failure: Closing the Gaps

In the United States, heart failure (HF) affects about 5.7 million adults, accounts for >1 million hospitalizations annually, and is the leading cause of hospitalization for adults >65 years of age. Despite diagnostic and therapeutic advances in the last several decades and improved survival rates, roughly 50% of people with HF die within 5 years of diagnosis. Rates of cardiovascular death or HF-r ...

  • Online Presentation Online Presentation
  • ACCME

netStride Test: Improving Outcomes in Patients with Heart Failure: Closing the Gaps

netStride Test: netStride Test: In the United States, heart failure (HF) affects about 5.7 million adults, accounts for >1 million hospitalizations annually, and is the leading cause of hospitalization for adults >65 years of age. Despite diagnostic and therapeutic advances in the last several decades and improved survival rates, roughly 50% of people with HF die within 5 years of diagnosis. Rates ...

  • Online Presentation Online Presentation
  • AAFP

Stroke Prevention in Atrial Fibrillation: Current Evidence for Tailoring Antithrombotic Therapy (Program ID: 15111981)

Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 million people in the United States. AF is an independent risk factor for ischemic stroke severity, recurrence, and mortality. Individuals with AF have a 4 to 5 times greater risk for ischemic stroke. The National Stroke Association emphasizes the importanc ...

  • Online Presentation
  • AANP
Main Menu
EDITOR'S PICKS